{{Rsnum
|rsid=6438552
|Gene=GSK3B
|Chromosome=3
|position=119912967
|Orientation=plus
|GMAF=0.4509
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=GSK3B
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 43.4 | 47.8 | 8.8
| HCB | 20.7 | 54.8 | 24.4
| JPT | 22.1 | 45.1 | 32.7
| YRI | 0.0 | 3.4 | 96.6
| ASW | 1.8 | 29.8 | 68.4
| CHB | 20.7 | 54.8 | 24.4
| CHD | 17.8 | 51.4 | 30.8
| GIH | 24.8 | 47.5 | 27.7
| LWK | 0.0 | 14.5 | 85.5
| MEX | 39.7 | 51.7 | 8.6
| MKK | 5.1 | 37.2 | 57.7
| TSI | 28.7 | 57.4 | 13.9
| HapMapRevision=28
}}may influence [[Parkinson's disease]]

{{PMID Auto
|PMID=19573950
|Title=GSK3beta polymorphisms, MAPT H1 haplotype and Parkinson's disease in a Greek cohort
}}

{{omim
|desc=GLYCOGEN SYNTHASE KINASE 3-BETA; GSK3B
|id=605004
|rsnum=6438552
}}

[http://archpsyc.ama-assn.org/cgi/content/short/66/7/721 abstract] may influence brain structure

{{PMID Auto
|PMID=20039940
|Title=Synergistic effect of two oxidative stress-related genes (heme oxygenase-1 and GSK3beta) on the risk of Parkinson's disease
}}

{{PMID Auto
|PMID=20605420
|Title=Association study of the GSK-3B gene with tardive dyskinesia in European Caucasians
}}
{{PMID Auto
|PMID=20055739
|Title=Role of glycogen synthase kinase 3 (GSK-3) in innate immune response of human immature dendritic cells to Aspergillus fumigatus
}}
{{PMID Auto
|PMID=21159074
|Title=SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study
}}

{{PMID Auto
|PMID=16315267
|Title=GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.
}}

{{PMID Auto
|PMID=19581563
|Title=Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder.
}}

{{PMID Auto
|PMID=21527318
|Title=GSK3beta genetic variability in patients with Multiple Sclerosis.
}}

{{PMID Auto
|PMID=23021822
|Title=Glycogen synthase kinase 3β gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium
}}

{{PMID Auto
|PMID=21130530
|Title=Role of tau kinases (CDK5R1 and GSK3B) in Parkinson's disease: a study from India
}}

{{PMID Auto
|PMID=23525328
|Title=Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype
|OA=1
}}

{{PMID Auto
|PMID=23030648
|Title=Possible association of the GSK3beta gene with the anxiety symptoms of major depressive disorder and P300 waveform.
|OA=1
}}

{{PMID Auto
|PMID=23628795
|Title=The association between glycogen synthase kinase 3 beta polymorphisms and Parkinson's disease susceptibility: a meta-analysis.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}